Literature DB >> 32957136

Hyperbaric oxygen therapy in a patient with Guillain-Barré syndrome receiving mechanical ventilation.

Lisha Song1, Baopeng Xing1, Weimin Yang1, Haifeng Li1,2.   

Abstract

The mortality rate of patients with Guillain-Barré syndrome (GBS) who develop respiratory muscle paralysis and need mechanical ventilation is increased. Though an unestablished indication, hyperbaric oxygen treatment (HBOT) has been used to treat patients with mild GBS who do not have respiratory muscle paralysis. The use of HBOT in severe cases has not been reported. We present a patient with severe GBS who received HBOT while ventilated in a multiplace hyperbaric chamber. Three courses of HBOT (one session per day, 10 sessions per course) were administered with a 2-day rest period between each course. The HBOT protocol was 40 minutes at 220 kPa with 25 minutes of compression and decompression. Following weeks of gradual deterioration, motor function improved after the first HBOT session. After eight HBOT sessions, the patient was successfully discontinued from mechanical ventilation and after 10 sessions the patient's muscle strength was significantly improved. After 30 HBOT sessions, the patient had normal breathing and speech, and did not cough when eating. Upper limb muscle strength was graded as 4 on the Medical Research Council (MRC) scale, lower limb muscle strength was graded as MRC 3. The patient was successfully discharged. Mechanically ventilated GBS patients may benefit from HBOT but studies are required to separate spontaneous recovery rates from treatment benefit. Copyright: This article is the copyright of the authors who grant Diving and Hyperbaric Medicine a non-exclusive licence to publish the article in electronic and other forms.

Entities:  

Keywords:  Case reports; Intensive care medicine; Neurology; Spinal cord injury

Mesh:

Substances:

Year:  2020        PMID: 32957136      PMCID: PMC7819725          DOI: 10.28920/dhm50.3.303-305

Source DB:  PubMed          Journal:  Diving Hyperb Med        ISSN: 1833-3516            Impact factor:   0.887


  9 in total

Review 1.  Guillain-Barré syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data.

Authors:  James J Sejvar; Katrin S Kohl; Jane Gidudu; Anthony Amato; Nandini Bakshi; Roger Baxter; Dale R Burwen; David R Cornblath; Jan Cleerbout; Kathryn M Edwards; Ulrich Heininger; Richard Hughes; Najwa Khuri-Bulos; Rudolf Korinthenberg; Barbara J Law; Ursula Munro; Helena C Maltezou; Patricia Nell; James Oleske; Robert Sparks; Priscilla Velentgas; Patricia Vermeer; Max Wiznitzer
Journal:  Vaccine       Date:  2010-06-18       Impact factor: 3.641

2.  The effect of different application timings of hyperbaric oxygen treatment on nerve regeneration in rats.

Authors:  Bilsev Ince; Abdullah Arslan; Mehmet Dadaci; Pembe Oltulu; Fatma Bilgen
Journal:  Microsurgery       Date:  2016-01-16       Impact factor: 2.425

3.  Effects of hyperbaric oxygen on peripheral nerves.

Authors:  Raquel Eguiluz-Ordoñez; Cuauhtémoc E Sánchez; Aureliano Venegas; Víctor Figueroa-Granados; Rogelio Hernández-Pando
Journal:  Plast Reconstr Surg       Date:  2006-08       Impact factor: 4.730

Review 4.  Unestablished indications for hyperbaric oxygen therapy.

Authors:  Simon J Mitchell; Michael H Bennett
Journal:  Diving Hyperb Med       Date:  2014-12       Impact factor: 0.887

Review 5.  The role of immunotherapy in Guillain-Barré syndrome: understanding the mechanism of action.

Authors:  Nortina Shahrizaila; Nobuhiro Yuki
Journal:  Expert Opin Pharmacother       Date:  2011-04-07       Impact factor: 3.889

6.  Functional evaluation of peripheral-nerve repair and the effect of hyperbaric oxygen.

Authors:  W A Zamboni; R E Brown; A C Roth; A Mathur; L L Stephenson
Journal:  J Reconstr Microsurg       Date:  1995-01       Impact factor: 2.873

7.  Hyperbaric oxygen versus steroid in facial nerve injury: an experimental animal study.

Authors:  Sema Zer Toros; Çiğdem Tepe Karaca; Pembegül Güneş; Çağatay Oysu; Çiğdem Kalaycık Ertugay; Barış Naiboğlu; Emin Elbüken; Erol Egeli
Journal:  Am J Otolaryngol       Date:  2013-07-26       Impact factor: 1.808

8.  Diagnosis of Guillain-Barré syndrome and validation of Brighton criteria.

Authors:  Christiaan Fokke; Bianca van den Berg; Judith Drenthen; Christa Walgaard; Pieter Antoon van Doorn; Bart Casper Jacobs
Journal:  Brain       Date:  2013-10-26       Impact factor: 13.501

Review 9.  Diagnosis and management of Guillain-Barré syndrome in ten steps.

Authors:  Sonja E Leonhard; Melissa R Mandarakas; Francisco A A Gondim; Kathleen Bateman; Maria L B Ferreira; David R Cornblath; Pieter A van Doorn; Mario E Dourado; Richard A C Hughes; Badrul Islam; Susumu Kusunoki; Carlos A Pardo; Ricardo Reisin; James J Sejvar; Nortina Shahrizaila; Cristiane Soares; Thirugnanam Umapathi; Yuzhong Wang; Eppie M Yiu; Hugh J Willison; Bart C Jacobs
Journal:  Nat Rev Neurol       Date:  2019-09-20       Impact factor: 42.937

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.